Missing data of some variables from hospitalized patients, such as detailed information of blood pressure and laboratory data including interleukin (IL)-6, brain natriuretic peptide (BNP), myoglobin, and troponin I, made it impossible to characterize differences in new-onset disorders (such as diabetes, hypertension, gastrointestinal and cardiac symptoms) for COVID-19 patients between different stages of the pandemic. Here, NPPB is linked to hypertensive disorder.